快而精医药(QGEN)

49.22 -1.13 -2.2443%

今开:49.31昨收:50.35
最高:49.61 最低:49.13
涨停价:0.0跌停价:0.0
总市值:1.1207394E10

快而精医药的热门评论

美股滚雪球2021-11-04 11:25

有报道称$快而精医药(QGEN)$ 吸引了法国诊断公司bioMérieux的收购兴趣。
去年,$赛默飞世尔科技(TMO)$ 出价104亿欧元收购QGEN,但最终交易破裂,一周后Qigen董事长辞职,这次董事长还辞职吗?
$东方生物(SH688298)$查看全文

美股滚雪球2021-11-17 12:09

$赛默飞世尔科技(TMO)$ 据说又想并购$快而精医药(QGEN)$ 了,念念不忘,必有回响。$义翘神州(SZ301047)$查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

7X24快讯2021-07-12 23:14

市场消息:快而精医药(QGEN.N)将回购高达1亿美元股票。查看全文

JZee2021-06-21 09:41

$泛生子(GTH)$ 主页上有$快而精医药(QGEN)$ 合作字样。泛生子目前的检测服务和未来的肝癌早筛需给qiagen分成么?//@userfield:回复@张小丰:我倒是觉得这个行业现在不需要一口吃个胖子吧,应该是渐进式进步,先比临床日常用的检测方法有更好的灵敏度和特异性,然后采样方便,这样就有一定优势,可以...查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

快而精医药(QGEN)2021-05-05 18:42

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000031 Act: 34 Size: 1 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

chuminhua2020-08-15 21:30

8/13,Qiagen$快而精医药(QGEN)$ 的投资者拒绝了Thermo Fisher$赛默飞世尔科技(TMO)$ 数十亿美元的收购提议。两家公司在3月达成115亿美元的收购交易,因COVID-19疫情,收购价于7月又提升至125亿美元。但还是不够,股东们认为,疫情的规模和持续证明了分子诊断日益重要,公司已经制定了将试剂产量翻...查看全文

快而精医药(QGEN)2020-08-14 05:18

$快而精医药(QGEN)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-20-219265 Act: 34 Size: 54 KB 网页链接查看全文

快而精医药(QGEN)2020-08-14 02:03

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000049 Act: 34 Size: 86 KB 网页链接查看全文

快而精医药(QGEN)2020-08-11 21:35

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-093070 Act: 34 Size: 143 KB 网页链接查看全文

快而精医药(QGEN)2020-08-10 21:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-092459 Act: 34 Size: 139 KB 网页链接查看全文

快而精医药(QGEN)2020-08-07 21:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-091783 Act: 34 Size: 137 KB 网页链接查看全文

快而精医药(QGEN)2020-08-06 21:15

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-091177 Act: 34 Size: 135 KB 网页链接查看全文

快而精医药(QGEN)2020-08-06 04:20

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-090837 Act: 34 Size: 134 KB 网页链接查看全文

快而精医药(QGEN)2020-08-05 18:15

$快而精医药(QGEN)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-20-209618 Act: 34 Size: 312 KB 网页链接查看全文

快而精医药(QGEN)2020-08-05 18:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-090398 Act: 34 Size: 152 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30